Ovarian Cancer Archive - Seite 4 von 8 - IOZK

Therapeutic DC vaccination with IL-2 as a consolidation therapy for ovarian cancer patients: a phase I/II trial

2014-06-30/in Dendritic Cells, International Publications, Ovarian Cancer /von 2014-06-30 / Cell. Mol. Immunol. 2015 Jan;12(1):87-95

Ovarian cancer biology and immunotherapy

2014-06-09/in Dendritic Cells, International Publications, Ovarian Cancer /von 2014-06-09 / Int. Rev. Immunol. 2014 Oct;33(5):428-40

Autologous dendritic cell vaccination (DCVAC/OvCa) added to standard of care therapy in three open-label randomized phase 2 studies in women with advanced stage ovarian cancer (OC).

2014-06-01/in Dendritic Cells, International Publications, Ovarian Cancer /von 2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr TPS3134)

The feasibility and clinical effects of dendritic cell-based immunotherapy targeting synthesized peptides for recurrent ovarian cancer

2014-05-07/in Dendritic Cells, International Publications, Ovarian Cancer /von 2014-05-07 / J Ovarian Res 2014 May;7:48

Wilms‘ tumor gene 1 immunotherapy in pelvic gynecological malignancies

2014-05-02/in Dendritic Cells, International Publications, IOZK Veröffentlichungen, Ovarian Cancer, Uterine Cancer /von 2014-05-02 / Expert Rev Clin Immunol 2014 Jun;10(6):705-11

Dendritic cell vaccination, immune regulation, and clinical outcomes in ovarian cancer

2013-11-18/in Dendritic Cells, International Publications, Ovarian Cancer /von 2013-11-18 / Front Immunol 2013 Nov;4:382

Dendritic cell-based immunotherapy in ovarian cancer

2013-11-06/in Dendritic Cells, International Publications, IOZK Veröffentlichungen, Ovarian Cancer /von 2013-11-06 / Oncoimmunology 2013 Dec;2(12):e27059

Immunological response after WT1 mRNA-loaded dendritic cell immunotherapy in ovarian carcinoma and carcinosarcoma

2013-09-01/in Dendritic Cells, International Publications, IOZK Veröffentlichungen, Ovarian Cancer /von 2013-09-01 / Anticancer Res. 2013 Sep;33(9):3855-9

A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside

2013-07-09/in Dendritic Cells, International Publications, Ovarian Cancer /von 2013-07-09 / Clin. Cancer Res. 2013 Sep;19(17):4801-15

A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer

2013-06-18/in Dendritic Cells, International Publications, Ovarian Cancer /von 2013-06-18 / J Transl Med 2013 Jun;11:149